Trial intelligence / Profile preview

Modafinil for Post-TBI Fatigue

NCT00233090Phase 2Terminated

Sponsor
Icahn School of Medicine at Mount Sinai
Start
Jul 2005
Primary completion
Dec 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in fatigue comparing Modafinil with Placebo (2 arms). Primary endpoint: Fatigue Severity at 4 weeks. Started Jul 2005; status: terminated.

02

Drugs

modafinil
03

Conditions

fatigue

Beyond the preview

Go deeper on NCT00233090.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00233090.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call